Login
$PURR
$9.85 +$0.78 (8.6%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2026
As of Jun 30, 2026
Q3 FY2026
As of Mar 31, 2026
Q2 FY2026
As of Dec 31, 2025
Q1 FY2026
As of Sep 30, 2025
Assets
Current assets
Cash and cash equivalents
Prepaids and other current assets
Receivable from related party
Total current assets
HYPE digital assets
Equity method investment
Other non-current assets
Total assets
Liabilities and stockholders' equity (deficit)
Current liabilities
Accounts payable and accrued expenses
Due to related parties
Accounts payable
Other current liabilities
Total current liabilities
Deferred tax liability
Total liabilities
Stockholders' equity (deficit):
Series A Preferred stock, $0.01 par value, 100,000,000 and 0 shares authorized as of June 30, 2026 and June 30, 2025, respectively; 166,173 and 0 shares issued and outstanding as of June 30, 2026, and June 30, 2025, respectively
Common stock, $0.01 par value, 2,000,000,000 and 0 shares authorized as of June 30, 2026 and June 30, 2025, respectively; 203,617,555 shares issued and 200,550,458 shares outstanding (excluding treasury shares of 3,067,097) as of June 30, 2026, and 0 shares issued and 0 shares outstanding (excluding treasury shares of 0) as of June 30, 2025
Additional paid-in capital
Retained earnings (accumulated deficit)
Treasury stock, at cost; 3,067,097 and 0 shares as of June 30, 2026, and June 30, 2025, respectively
Total stockholders' equity (deficit)
Total liabilities and stockholders' equity (deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support